Østerrike - tysk - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sanofi-aventis gmbh - alfuzosin hydrochlorid - alfuzosin

Østerrike - tysk - AGES (Agentur für Gesundheit und Ernährungssicherheit)

stada arzneimittel gmbh - alfuzosin hydrochlorid - alfuzosin

Østerrike - tysk - AGES (Agentur für Gesundheit und Ernährungssicherheit)

stada arzneimittel gmbh - alfuzosin hydrochlorid - alfuzosin

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

ratiopharm gmbh* - alfuzosinum hýdróklóríð - forðatafla - 10 mg

USA - engelsk - NLM (National Library of Medicine)

camber pharmaceuticals - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg - alfuzosin hydrochloride is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. alfuzosin hydrochloride is not indicated for the treatment of hypertension. alfuzosin hydrochloride is not indicated for use in the pediatric population. alfuzosin hydrochloride is contraindicated for use: - in patients with moderate or severe hepatic impairment (childs-pugh categories b and c), since alfuzosin blood levels are increased in these patients [see use in specific populations (8.7) and clinical pharmacology (12.3)] . - with potent cyp3a4 inhibitors such as ketoconazole, itraconazole, and ritonavir, since alfuzosin blood levels are increased [see drug interactions (7.1) and clinical pharmacology (12.3)] . - in patients with known hypersensitivity, such as urticaria and angioedema, to alfuzosinhydrochloride or any component of alfuzosin hydrochloride tablets [see adverse reactions (6.2)] pregnancy category b. alfuzosin hydrochloride is not indicated for use in women, and there are no studie

Sveits - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - alfuzosini hydrochloridum - retardtabletten - alfuzosini hydrochloridum 10 mg, hypromellosum, oleum vegetabile hydrogenatum, calcii hydrogenophosphas dihydricus, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, propylenglycolum, e 171, pro compresso obducto. - benigne prostatahyperplasie - synthetika

Belgia - tysk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - alfuzosin hydrochlorid - retardtablette - 5 mg - alfuzosin hydrochlorid 5 mg - alfuzosin

Belgia - tysk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - alfuzosin hydrochlorid - retardtablette - 10 mg - alfuzosin hydrochlorid 10 mg - alfuzosin

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

towa pharmaceutical s.p.a. - alfuzosina - alfuzosina

Ungarn - ungarsk - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

teva magyarország zrt. - alfuzosin -